Patricia Inácio, PhD,  science writer—

The Chronic Obstructive Pulmonary Disease Foundation and DevPro Biopharma have established a partnership to develop new therapies for people with chronic obstructive pulmonary disease (COPD) and other lung disorders. The collaborators will work to identify potential therapies and speed their development and possible regulatory approval. The aim is to enable new treatments…

Patients with chronic obstructive pulmonary disease (COPD) are more likely to develop ventricular arrhythmia, a heart rhythm disorder affecting the heart’s lower chambers or ventricles, than people without the disease, according to a Taiwanese nationwide study. Later analysis of that study also found that people with both COPD and…

A new collaboration is seeking to bring quantitative imaging analysis to diagnosis and care of patients with chronic lung diseases, including chronic obstructive pulmonary disease (COPD) and emphysema. The agreement is between Spesana, a healthcare platform focused on molecular diagnostics and in building an accessible database for physicians,…

People in China with chronic obstructive pulmonary disease (COPD) are overusing inhaled corticosteroids and underusing non-pharmacological therapies such as home oxygen therapy, a study suggests. The real-world data show that treatment of COPD patients fails to follow the 2017 revised Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines.

The European Commission has approved AstraZeneca‘s triple combination therapy Trixeo Aerosphere as a maintenance treatment for chronic obstructive pulmonary disease (COPD). The approval, which follows a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), covers the therapy’s use in adults with moderate-to-severe COPD…

Nuvaira’s targeted lung denervation (TLD) therapy lowers the risk of hospitalization due to exacerbations in people with chronic obstructive pulmonary disease (COPD), Phase 2 trial data show, according to a company press release. A new clinical study, called AIRFLOW-3 (NCT03639051), is currently recruiting COPD patients at multiple…

Use of electronic cigarettes (e-cigarettes) is associated with an increased risk of respiratory diseases, including chronic obstructive pulmonary disease (COPD), among young adults, irrespective of other tobacco product use, a large U.S.-based study shows. Compared to healthy people, those currently using e-cigarettes, commonly called vaping, had a 43% increased…

Exposure to cigarette smoke during pregnancy impairs lung embryonic development, which may increase the baby’s later-in-life risk for disorders like chronic obstructive pulmonary disease (COPD), a mouse study suggests. Smoke was found to increase the levels of the amphiregulin (AREG) protein, which may impair the formation of certain…

A single dose of a pressurized metered-dose inhaler formulation of ensifentrine (RPL544) significantly improved lung function, compared to a placebo, in people with moderate-to-severe chronic obstructive pulmonary disease (COPD), Verona Pharma announced. These results are from part A, the single-dose part, of a Phase 2 trial (NCT04091360) underway in two…

With the prevalence of type 2 diabetes and chronic obstructive pulmonary disease (COPD) rising, a team of researchers is discussing the latest research linking both diseases, and the recommended therapeutic approaches for patients with coexisting COPD and diabetes. The study “COPD and Type 2 Diabetes,” published in the journal…